Global Group A and C Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2024-2030

Page: 131

Published Date: 21 Aug 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Group A and C Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Group A and C Meningococcal Polysaccharide Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Group A and C Meningococcal Polysaccharide Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Group A and C Meningococcal Polysaccharide Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Group A and C Meningococcal Polysaccharide Vaccine total production and demand, 2019-2030, (Dose)
Global Group A and C Meningococcal Polysaccharide Vaccine total production value, 2019-2030, (USD Million)
Global Group A and C Meningococcal Polysaccharide Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Dose), (based on production site)
Global Group A and C Meningococcal Polysaccharide Vaccine consumption by region & country, CAGR, 2019-2030 & (Dose)
U.S. VS China: Group A and C Meningococcal Polysaccharide Vaccine domestic production, consumption, key domestic manufacturers and share
Global Group A and C Meningococcal Polysaccharide Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Dose)
Global Group A and C Meningococcal Polysaccharide Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Dose)
Global Group A and C Meningococcal Polysaccharide Vaccine production by Application, production, value, CAGR, 2019-2030, (USD Million) & (Dose)
This report profiles key players in the global Group A and C Meningococcal Polysaccharide Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biological, Toyouvax, Walvax, AIM Bio, Lanzhou Institute of Biological Products, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Group A and C Meningococcal Polysaccharide Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Group A and C Meningococcal Polysaccharide Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Group A and C Meningococcal Polysaccharide Vaccine Market, Segmentation by Type:
    Polysaccharide Vaccine
    Polysaccharide-protein Conjugate Vaccine

Global Group A and C Meningococcal Polysaccharide Vaccine Market, Segmentation by Application:
    Hospital
    Centers for Disease Control and Prevention
    Others

Companies Profiled:
    Pfizer
    Sanofi Pasteur
    GlaxoSmithKline
    Merck & Co.
    Royal (Wuxi) Bio-Pharmaceutical
    Zhifei Biological
    Toyouvax
    Walvax
    AIM Bio
    Lanzhou Institute of Biological Products
    Cansino Biologics
    Chengda Biotechnology
    Sinovac

Key Questions Answered:
1. How big is the global Group A and C Meningococcal Polysaccharide Vaccine market?
2. What is the demand of the global Group A and C Meningococcal Polysaccharide Vaccine market?
3. What is the year over year growth of the global Group A and C Meningococcal Polysaccharide Vaccine market?
4. What is the production and production value of the global Group A and C Meningococcal Polysaccharide Vaccine market?
5. Who are the key producers in the global Group A and C Meningococcal Polysaccharide Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Group A and C Meningococcal Polysaccharide Vaccine Introduction
    1.2 World Group A and C Meningococcal Polysaccharide Vaccine Supply & Forecast
        1.2.1 World Group A and C Meningococcal Polysaccharide Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2030)
        1.2.3 World Group A and C Meningococcal Polysaccharide Vaccine Pricing Trends (2019-2030)
    1.3 World Group A and C Meningococcal Polysaccharide Vaccine Production by Region (Based on Production Site)
        1.3.1 World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Region (2019-2030)
        1.3.2 World Group A and C Meningococcal Polysaccharide Vaccine Production by Region (2019-2030)
        1.3.3 World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2030)
        1.3.5 Europe Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2030)
        1.3.6 China Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Group A and C Meningococcal Polysaccharide Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Group A and C Meningococcal Polysaccharide Vaccine Major Market Trends

2 Demand Summary
    2.1 World Group A and C Meningococcal Polysaccharide Vaccine Demand (2019-2030)
    2.2 World Group A and C Meningococcal Polysaccharide Vaccine Consumption by Region
        2.2.1 World Group A and C Meningococcal Polysaccharide Vaccine Consumption by Region (2019-2024)
        2.2.2 World Group A and C Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
    2.4 China Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
    2.5 Europe Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
    2.6 Japan Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
    2.7 South Korea Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
    2.8 ASEAN Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
    2.9 India Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Group A and C Meningococcal Polysaccharide Vaccine Production by Manufacturer (2019-2024)
    3.3 World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Group A and C Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Group A and C Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Group A and C Meningococcal Polysaccharide Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Group A and C Meningococcal Polysaccharide Vaccine in 2023
    3.6 Group A and C Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Group A and C Meningococcal Polysaccharide Vaccine Market: Region Footprint
        3.6.2 Group A and C Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
        3.6.3 Group A and C Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Production Value Comparison
        4.1.1 United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Production Comparison
        4.2.1 United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Consumption Comparison
        4.3.1 United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Group A and C Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Group A and C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2024)
    4.5 China Based Group A and C Meningococcal Polysaccharide Vaccine Manufacturers and Market Share
        4.5.1 China Based Group A and C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2024)
    4.6 Rest of World Based Group A and C Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Group A and C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Group A and C Meningococcal Polysaccharide Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Polysaccharide Vaccine
        5.2.2 Polysaccharide-protein Conjugate Vaccine
    5.3 Market Segment by Type
        5.3.1 World Group A and C Meningococcal Polysaccharide Vaccine Production by Type (2019-2030)
        5.3.2 World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Type (2019-2030)
        5.3.3 World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Group A and C Meningococcal Polysaccharide Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Centers for Disease Control and Prevention
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Group A and C Meningococcal Polysaccharide Vaccine Production by Application (2019-2030)
        6.3.2 World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Application (2019-2030)
        6.3.3 World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.1.4 Pfizer Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 Sanofi Pasteur
        7.2.1 Sanofi Pasteur Details
        7.2.2 Sanofi Pasteur Major Business
        7.2.3 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.2.4 Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Sanofi Pasteur Recent Developments/Updates
        7.2.6 Sanofi Pasteur Competitive Strengths & Weaknesses
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Details
        7.3.2 GlaxoSmithKline Major Business
        7.3.3 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.3.4 GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 GlaxoSmithKline Recent Developments/Updates
        7.3.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.4 Merck & Co.
        7.4.1 Merck & Co. Details
        7.4.2 Merck & Co. Major Business
        7.4.3 Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.4.4 Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Merck & Co. Recent Developments/Updates
        7.4.6 Merck & Co. Competitive Strengths & Weaknesses
    7.5 Royal (Wuxi) Bio-Pharmaceutical
        7.5.1 Royal (Wuxi) Bio-Pharmaceutical Details
        7.5.2 Royal (Wuxi) Bio-Pharmaceutical Major Business
        7.5.3 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.5.4 Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
        7.5.6 Royal (Wuxi) Bio-Pharmaceutical Competitive Strengths & Weaknesses
    7.6 Zhifei Biological
        7.6.1 Zhifei Biological Details
        7.6.2 Zhifei Biological Major Business
        7.6.3 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.6.4 Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Zhifei Biological Recent Developments/Updates
        7.6.6 Zhifei Biological Competitive Strengths & Weaknesses
    7.7 Toyouvax
        7.7.1 Toyouvax Details
        7.7.2 Toyouvax Major Business
        7.7.3 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.7.4 Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Toyouvax Recent Developments/Updates
        7.7.6 Toyouvax Competitive Strengths & Weaknesses
    7.8 Walvax
        7.8.1 Walvax Details
        7.8.2 Walvax Major Business
        7.8.3 Walvax Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.8.4 Walvax Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Walvax Recent Developments/Updates
        7.8.6 Walvax Competitive Strengths & Weaknesses
    7.9 AIM Bio
        7.9.1 AIM Bio Details
        7.9.2 AIM Bio Major Business
        7.9.3 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.9.4 AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 AIM Bio Recent Developments/Updates
        7.9.6 AIM Bio Competitive Strengths & Weaknesses
    7.10 Lanzhou Institute of Biological Products
        7.10.1 Lanzhou Institute of Biological Products Details
        7.10.2 Lanzhou Institute of Biological Products Major Business
        7.10.3 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.10.4 Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Lanzhou Institute of Biological Products Recent Developments/Updates
        7.10.6 Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
    7.11 Cansino Biologics
        7.11.1 Cansino Biologics Details
        7.11.2 Cansino Biologics Major Business
        7.11.3 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.11.4 Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Cansino Biologics Recent Developments/Updates
        7.11.6 Cansino Biologics Competitive Strengths & Weaknesses
    7.12 Chengda Biotechnology
        7.12.1 Chengda Biotechnology Details
        7.12.2 Chengda Biotechnology Major Business
        7.12.3 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.12.4 Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Chengda Biotechnology Recent Developments/Updates
        7.12.6 Chengda Biotechnology Competitive Strengths & Weaknesses
    7.13 Sinovac
        7.13.1 Sinovac Details
        7.13.2 Sinovac Major Business
        7.13.3 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product and Services
        7.13.4 Sinovac Group A and C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Sinovac Recent Developments/Updates
        7.13.6 Sinovac Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Group A and C Meningococcal Polysaccharide Vaccine Industry Chain
    8.2 Group A and C Meningococcal Polysaccharide Vaccine Upstream Analysis
        8.2.1 Group A and C Meningococcal Polysaccharide Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Group A and C Meningococcal Polysaccharide Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Group A and C Meningococcal Polysaccharide Vaccine Production Mode
    8.6 Group A and C Meningococcal Polysaccharide Vaccine Procurement Model
    8.7 Group A and C Meningococcal Polysaccharide Vaccine Industry Sales Model and Sales Channels
        8.7.1 Group A and C Meningococcal Polysaccharide Vaccine Sales Model
        8.7.2 Group A and C Meningococcal Polysaccharide Vaccine Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2019-2024)
 Table 5. World Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2025-2030)
 Table 6. World Group A and C Meningococcal Polysaccharide Vaccine Production by Region (2019-2024) & (Dose)
 Table 7. World Group A and C Meningococcal Polysaccharide Vaccine Production by Region (2025-2030) & (Dose)
 Table 8. World Group A and C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2019-2024)
 Table 9. World Group A and C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2025-2030)
 Table 10. World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2024) & (US$/Dose)
 Table 11. World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Region (2025-2030) & (US$/Dose)
 Table 12. Group A and C Meningococcal Polysaccharide Vaccine Major Market Trends
 Table 13. World Group A and C Meningococcal Polysaccharide Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Dose)
 Table 14. World Group A and C Meningococcal Polysaccharide Vaccine Consumption by Region (2019-2024) & (Dose)
 Table 15. World Group A and C Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2025-2030) & (Dose)
 Table 16. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Group A and C Meningococcal Polysaccharide Vaccine Producers in 2023
 Table 18. World Group A and C Meningococcal Polysaccharide Vaccine Production by Manufacturer (2019-2024) & (Dose)
 Table 19. Production Market Share of Key Group A and C Meningococcal Polysaccharide Vaccine Producers in 2023
 Table 20. World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
 Table 21. Global Group A and C Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
 Table 22. World Group A and C Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Group A and C Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
 Table 24. Group A and C Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
 Table 25. Group A and C Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
 Table 26. Group A and C Meningococcal Polysaccharide Vaccine Competitive Factors
 Table 27. Group A and C Meningococcal Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
 Table 28. Group A and C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions Activity
 Table 29. United States VS China Group A and C Meningococcal Polysaccharide Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Group A and C Meningococcal Polysaccharide Vaccine Production Comparison, (2019 & 2023 & 2030) & (Dose)
 Table 31. United States VS China Group A and C Meningococcal Polysaccharide Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (Dose)
 Table 32. United States Based Group A and C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2024) & (Dose)
 Table 36. United States Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Market Share (2019-2024)
 Table 37. China Based Group A and C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production, (2019-2024) & (Dose)
 Table 41. China Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Market Share (2019-2024)
 Table 42. Rest of World Based Group A and C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production, (2019-2024) & (Dose)
 Table 46. Rest of World Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Market Share (2019-2024)
 Table 47. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Group A and C Meningococcal Polysaccharide Vaccine Production by Type (2019-2024) & (Dose)
 Table 49. World Group A and C Meningococcal Polysaccharide Vaccine Production by Type (2025-2030) & (Dose)
 Table 50. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2024) & (US$/Dose)
 Table 53. World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Type (2025-2030) & (US$/Dose)
 Table 54. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Group A and C Meningococcal Polysaccharide Vaccine Production by Application (2019-2024) & (Dose)
 Table 56. World Group A and C Meningococcal Polysaccharide Vaccine Production by Application (2025-2030) & (Dose)
 Table 57. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2024) & (US$/Dose)
 Table 60. World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Application (2025-2030) & (US$/Dose)
 Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 62. Pfizer Major Business
 Table 63. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 64. Pfizer Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Pfizer Recent Developments/Updates
 Table 66. Pfizer Competitive Strengths & Weaknesses
 Table 67. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
 Table 68. Sanofi Pasteur Major Business
 Table 69. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 70. Sanofi Pasteur Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Sanofi Pasteur Recent Developments/Updates
 Table 72. Sanofi Pasteur Competitive Strengths & Weaknesses
 Table 73. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
 Table 74. GlaxoSmithKline Major Business
 Table 75. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 76. GlaxoSmithKline Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. GlaxoSmithKline Recent Developments/Updates
 Table 78. GlaxoSmithKline Competitive Strengths & Weaknesses
 Table 79. Merck & Co. Basic Information, Manufacturing Base and Competitors
 Table 80. Merck & Co. Major Business
 Table 81. Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 82. Merck & Co. Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Merck & Co. Recent Developments/Updates
 Table 84. Merck & Co. Competitive Strengths & Weaknesses
 Table 85. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 86. Royal (Wuxi) Bio-Pharmaceutical Major Business
 Table 87. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 88. Royal (Wuxi) Bio-Pharmaceutical Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
 Table 90. Royal (Wuxi) Bio-Pharmaceutical Competitive Strengths & Weaknesses
 Table 91. Zhifei Biological Basic Information, Manufacturing Base and Competitors
 Table 92. Zhifei Biological Major Business
 Table 93. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 94. Zhifei Biological Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Zhifei Biological Recent Developments/Updates
 Table 96. Zhifei Biological Competitive Strengths & Weaknesses
 Table 97. Toyouvax Basic Information, Manufacturing Base and Competitors
 Table 98. Toyouvax Major Business
 Table 99. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 100. Toyouvax Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Toyouvax Recent Developments/Updates
 Table 102. Toyouvax Competitive Strengths & Weaknesses
 Table 103. Walvax Basic Information, Manufacturing Base and Competitors
 Table 104. Walvax Major Business
 Table 105. Walvax Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 106. Walvax Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Walvax Recent Developments/Updates
 Table 108. Walvax Competitive Strengths & Weaknesses
 Table 109. AIM Bio Basic Information, Manufacturing Base and Competitors
 Table 110. AIM Bio Major Business
 Table 111. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 112. AIM Bio Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. AIM Bio Recent Developments/Updates
 Table 114. AIM Bio Competitive Strengths & Weaknesses
 Table 115. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
 Table 116. Lanzhou Institute of Biological Products Major Business
 Table 117. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 118. Lanzhou Institute of Biological Products Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Lanzhou Institute of Biological Products Recent Developments/Updates
 Table 120. Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
 Table 121. Cansino Biologics Basic Information, Manufacturing Base and Competitors
 Table 122. Cansino Biologics Major Business
 Table 123. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 124. Cansino Biologics Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Cansino Biologics Recent Developments/Updates
 Table 126. Cansino Biologics Competitive Strengths & Weaknesses
 Table 127. Chengda Biotechnology Basic Information, Manufacturing Base and Competitors
 Table 128. Chengda Biotechnology Major Business
 Table 129. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 130. Chengda Biotechnology Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Chengda Biotechnology Recent Developments/Updates
 Table 132. Chengda Biotechnology Competitive Strengths & Weaknesses
 Table 133. Sinovac Basic Information, Manufacturing Base and Competitors
 Table 134. Sinovac Major Business
 Table 135. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Product and Services
 Table 136. Sinovac Group A and C Meningococcal Polysaccharide Vaccine Production (Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Sinovac Recent Developments/Updates
 Table 138. Sinovac Competitive Strengths & Weaknesses
 Table 139. Global Key Players of Group A and C Meningococcal Polysaccharide Vaccine Upstream (Raw Materials)
 Table 140. Global Group A and C Meningococcal Polysaccharide Vaccine Typical Customers
 Table 141. Group A and C Meningococcal Polysaccharide Vaccine Typical Distributors


List of Figures
 Figure 1. Group A and C Meningococcal Polysaccharide Vaccine Picture
 Figure 2. World Group A and C Meningococcal Polysaccharide Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Group A and C Meningococcal Polysaccharide Vaccine Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2030) & (Dose)
 Figure 5. World Group A and C Meningococcal Polysaccharide Vaccine Average Price (2019-2030) & (US$/Dose)
 Figure 6. World Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2019-2030)
 Figure 7. World Group A and C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2019-2030)
 Figure 8. North America Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2030) & (Dose)
 Figure 9. Europe Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2030) & (Dose)
 Figure 10. China Group A and C Meningococcal Polysaccharide Vaccine Production (2019-2030) & (Dose)
 Figure 11. Group A and C Meningococcal Polysaccharide Vaccine Market Drivers
 Figure 12. Factors Affecting Demand
 Figure 13. World Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (Dose)
 Figure 14. World Group A and C Meningococcal Polysaccharide Vaccine Consumption Market Share by Region (2019-2030)
 Figure 15. United States Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (Dose)
 Figure 16. China Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (Dose)
 Figure 17. Europe Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (Dose)
 Figure 18. Japan Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (Dose)
 Figure 19. South Korea Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (Dose)
 Figure 20. ASEAN Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (Dose)
 Figure 21. India Group A and C Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (Dose)
 Figure 22. Producer Shipments of Group A and C Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 23. Global Four-firm Concentration Ratios (CR4) for Group A and C Meningococcal Polysaccharide Vaccine Markets in 2023
 Figure 24. Global Four-firm Concentration Ratios (CR8) for Group A and C Meningococcal Polysaccharide Vaccine Markets in 2023
 Figure 25. United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 26. United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Group A and C Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Market Share 2023
 Figure 29. China Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Market Share 2023
 Figure 30. Rest of World Based Manufacturers Group A and C Meningococcal Polysaccharide Vaccine Production Market Share 2023
 Figure 31. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 32. World Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share by Type in 2023
 Figure 33. Polysaccharide Vaccine
 Figure 34. Polysaccharide-protein Conjugate Vaccine
 Figure 35. World Group A and C Meningococcal Polysaccharide Vaccine Production Market Share by Type (2019-2030)
 Figure 36. World Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share by Type (2019-2030)
 Figure 37. World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030) & (US$/Dose)
 Figure 38. World Group A and C Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 39. World Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share by Application in 2023
 Figure 40. Hospital
 Figure 41. Centers for Disease Control and Prevention
 Figure 42. Others
 Figure 43. World Group A and C Meningococcal Polysaccharide Vaccine Production Market Share by Application (2019-2030)
 Figure 44. World Group A and C Meningococcal Polysaccharide Vaccine Production Value Market Share by Application (2019-2030)
 Figure 45. World Group A and C Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030) & (US$/Dose)
 Figure 46. Group A and C Meningococcal Polysaccharide Vaccine Industry Chain
 Figure 47. Group A and C Meningococcal Polysaccharide Vaccine Procurement Model
 Figure 48. Group A and C Meningococcal Polysaccharide Vaccine Sales Model
 Figure 49. Group A and C Meningococcal Polysaccharide Vaccine Sales Channels, Direct Sales, and Distribution
 Figure 50. Methodology
 Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer
Sanofi Pasteur
GlaxoSmithKline
Merck & Co.
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biological
Toyouvax
Walvax
AIM Bio
Lanzhou Institute of Biological Products
Cansino Biologics
Chengda Biotechnology
Sinovac

Related Reports

Global Group A and C Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Group A and C Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 21 Aug 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Group A and C Meningococcal Polysaccharide Vaccine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

Product Tags

Group A and C Meningococcal Polysaccharide Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>